Innovation Exchange Amsterdam (IXA) is the joint knowledge transfer office of the Amsterdam universities
At every campus location throughout Amsterdam our business developers, legal advisors and grant advisors contribute to developing the Amsterdam innovation ecosystem by bringing together people. IXA drives the transition of scientific discoveries, research results and knowledge into ground breaking innovations and applications that improve lives, transform industries, and create substantial social and economic value.
The IXA workforce includes business developers, legal counsels, grants advisors, program managers and management staff. Rene van Lier is director of IXA. At nearly ten locations at the premises of the Amsterdam knowledge institutions the teams deploy their expertise and large network both to the benefit of the researches and external parties. All in view of IXA’s mission: Partnering science for impact.
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News